Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
Share
Copied
02:34
Germany on Thursday rejected a U.S. proposal to waive patent protection for COVID-19 vaccines, saying the greatest constraints were not intellectual property protection but vaccines' production capacity and their quality.